3,3-Bis(p-dimethylaminophenyl)-6-dimethylaminophthalide

3,3-ビス(p-ジメチルアミノフェニル)-6-ジメチルアミノフタリド


[CAS No. 1552-42-7]

Crystal Violet Lactone

クリスタルバイオレットラクトン

Molecular formula: C26H29N3O2 Molecular weight: 415.54

ABSTRACT

A single dose oral toxicity test of 3,3-bis(p-dimethylaminophenyl)-6-dimethylaminophthalide revealed an LD50 value of more than 2000 mg/kg for both sexes.

Oral toxicity of 3,3-bis(p-dimethylaminophenyl)-6-dimethylaminophthalide was studied in rats in a 28-day repeated dose toxicity test at dose levels of 0, 8, 30, 120, and 500 mg/kg. On histopathological examination, diffuse hypertrophy of follicular cells in the thyroid was apparent in both sexes receiving 500 mg/kg, along with hypertrophy of chief cells in the parathyroid and hepatocytes in the liver in males. These changes disappeared during the recovery period. There were no abnormalities in body weights, food consumption, hematology, blood chemistry, urinalysis or organ weights. The NOEL is considered to be 120 mg/kg/day for males and females from this study.

Genotoxicity of 3,3-bis(p-dimethylaminophenyl)-6-dimethylaminophthalide was studied by a reverse mutation test in bacteria. The substance was not mutagenic in Salmonella typhimurium TA100, TA1535, TA98, TA1537 or Escherichia coli WP2 uvrA, with or without an exogenous metabolic activation system.

Genotoxicity of 3,3-bis(p-dimethylaminophenyl)-6-dimethylaminophthalide was studied by the chromosomal aberration test in cultured Chinese hamster lung (CHL/IU) cells.

3,3-Bis(p-dimethylaminophenyl)-6-dimethylaminophthalide did not induce structural chromosomal aberrations or polyploidy up to 4.2 mg/mL (10 mmol/mL) under the present test conditions.

SUMMARIZED DATA FROM THE STUDIES

1. Single Dose Oral Toxicity 1)

Purity:99.5 %
Test species/strain:Rat/Crj:CD(SD)IGS
Test method:OECD Test Guideline 401
 Route:Oral (gavage)
 Dosage:0 (vehicle), 2000 mg/kg
 Number of animals/group:Males, 5; females, 5
 Vehicle:0.5 % Sodium carboxymethylcellulose mixed with 0.1 % Tween 80
GLP:Yes

 Test results:

No deaths occurred. No abnormalities were observed regarding clinical signs, body weights or necropsy findings.

The LD50 value is considered to be more than 2000 mg/kg for both sexes.

2. Repeated Dose Oral Toxicity 1)

Purity:99.5 %
Test species/strain:Rat/Crj:CD(SD)IGS
Test method:Guideline for the 28-Day Repeated Dose Toxicity Test in Mammalian Species (Chemical Substances Control Law of Japan)
 Route:Oral (gavage)
 Dosage:0 (vehicle), 8, 30, 120, 500 mg/kg/day
 Number of animals/groupMales, 12; females, 12 (0, 120, 500 mg/kg)
Males, 6; females, 6 (8, 30 mg/kg)
 Vehicle:0.5 % Sodium carboxymethylcellulose mixed with 0.1 % Tween 80
 Administration period:Males and females, 28 days
 Terminal killing:Days 29 or 43
GLP:Yes

 Test results:

Oral toxicity of 3,3-bis(p-dimethylaminophenyl)-6-dimethylaminophthalide was studied in rats in a 28-day repeat dose toxicity test at dose levels of 0, 8, 30, 120, and 500 mg/kg.

Diffuse hypertrophy of follicular cells in the thyroid, a frequent finding with many chemicals, was noted in both sexes.

Hypertrophy of chief cells in the parathyroid and hepatocytes in the liver was observed in males at 500 mg/kg.

These changes disappeared during the recovery period.

There were no abnormalities in clinical, body weights, food consumption, hematology, biochemical analysis, urinalysis or organ weights. The NOEL is considered to be 120 mg/kg/day for males and females from this study.

3. Genetic Toxicity

3-1. Bacterial test 2)

Purity:99.5 %
Test species/strain:Salmonella typhimurium TA100, TA1535, TA98, TA1537, Escherichia coli WP2 uvrA
Test method:Guidelines for Screening Mutagenicity Testing of Chemicals (Chemical Substances Control Law of Japan) and OECD Test Guideline 471
 Procedures:Pre-incubation method
 Solvent:Dimethyl sulfoxide
 Positive controls:-S9 mix; 2-(2-Furyl)-3-(5-nitro-2-furyl)acrylamide (TA100, TA98, WP2 uvrA), Sodium azide (TA1535) and 9-Aminoacridine (TA1537)
+S9 mix; 2-Aminoanthracene (five strains)
 Dosage:-S9 mix; 0, 313, 625, 1250, 2500, 5000 μg/plate (five strains)
+S9 mix; 0, 313, 625, 1250, 2500, 5000 μg/plate (five strains)
 S9:Rat liver, induced with phenobarbital and 5,6-benzoflavone
 Plates/test:3 (1 for the cytotoxicity test)
 Number of replicates:2 (plus 1 for the cytotoxicity test)
GLP:Yes

 Test results:

This chemical did not induce gene mutations in S. typhimurium TA100, TA98, TA1535, TA1537 or E. coli WP2 uvrA strains with or without S9 mix. Growth inhibition was not observed up to 5000 μg/plate in any strain, with or without S9 mix.

Genetic effects:
Salmonella typhimurium TA100, TA98, TA1535, TA1537
+?-
Without metabolic activation:[ ][ ][*]
With metabolic activation:[ ][ ][*]

Escherichia coli WP2 uvrA
+?-
Without metabolic activation:[ ][ ][*]
With metabolic activation:[ ][ ][*]

3-2. Non-bacterial in vitro test (chromosomal aberration test)2)

Purity:99.5 %
Type of cell used:Chinese hamster lung (CHL/IU) cells
Test method:Guidelines for Screening Mutagenicity Testing of Chemicals (Chemical Substances Control Law of Japan) and OECD Test Guideline 473
 Vehicle:0.5 % Sodium carboxymethylcellulose
 Positive controls:-S9 mix; Mitomycin C
+S9 mix; Cyclophosphamide
 Dosage:-S9 mix (continuous treatment); 0, 1.1, 2.1, 4.2 mg/mL
-S9 mix (short-term treatment); 0, 1.1, 2.1, 4.2 mg/mL
+S9 mix (short-term treatment); 0, 1.1, 2.1, 4.2 mg/mL
 S9:Rat liver, induced with phenobarbital and 5,6-benzoflavone
 Plates/test:2
GLP:Yes

 Test results:

Cells with structural chromosomal aberrations were not significantly increased at any dose. Polyploidy was significantly induced at 4.2 mg/mL with the 24 hr continuous treatment. However, we judged the result as negative because of the low frequency (1.93 %).

Genotoxic effects:
clastogenicitypolyploidy
+?-+?-
Without metabolic activation:[ ][ ][*][ ][ ][*]
With metabolic activation:[ ][ ][*][ ][ ][*]

1)The tests were performed by the Kashima Laboratory, Mitsubishi Chemical Safety Institute Ltd., 14 Sunayama, Hasaki-machi, Kashima-gun, Ibaraki, 314-0255, Japan. Tel +81-479-46-2871 Fax +81-479-46-2874
2)The tests were performed by the Hatano Research Institute, Food and Drug Safety Center, 729-5 Ochiai, Hadano-shi, Kanagawa, 257-8523, Japan. Tel +81-463-82-4751 Fax +81-463-82-9627